Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Molecular Cancer
|
March 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
Song-Yang Wu, Ying Xu, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
Li Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
The New England Journal of Medicine
|
March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
Guo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Molecular Cancer
|
March 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
Song-Yang Wu, Ying Xu, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
Li Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
The New England Journal of Medicine
|
March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
Guo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Page
of 5